RecruitingNCT06866418

Phagenyx® Registry Study

Phagenyx® Registry Study: Evaluating Swallowing Therapy Outcomes and Recovery in the U.S.


Sponsor

Phagenesis Ltd.

Enrollment

600 participants

Start Date

Sep 15, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

A retrospective, open-label, matched-control registry study designed to characterize the effectiveness of Pharyngeal Electrical Stimulation (PES) to improve swallowing in patients with severe dysphagia post stroke when delivered using the Phagenyx® System in real-world clinical settings in hospitals in the United States of America (US).


Eligibility

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called 1. Phagenyx® System Group Patients for people with dysphagia. The study is currently recruiting participants at 2 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICE1. Phagenyx® System Group Patients

Patients who have undergone Pharyngeal Electrical Stimulation (PES) treatment for severe dysphagia using the Phagenyx® System


Locations(3)

Banner University Medical Center

Phoenix, Arizona, United States

HMH Jersey Shore University Medical Center

Neptune City, New Jersey, United States

University of Texas

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06866418


Related Trials